Pancreatic Cancer Research

ReviewPharmacol Res2022

Overcoming immunotherapeutic resistance in PDAC: SIRPα-CD47 blockade.

Journal
Pharmacol Res
Published
18 May 2022
Citations
16
Type
Review

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

A daily increase in the number of new cases of pancreatic ductal adenocarcinoma remains an issue of contention in cancer research. The data revealed that a global cumulated case of about 500, 000 have been reported. … Excerpt only: this text is the publisher’s. Read it in full at the source.